Begoña Brera

704 total citations
16 papers, 579 citations indexed

About

Begoña Brera is a scholar working on Neurology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Begoña Brera has authored 16 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Neurology, 7 papers in Cellular and Molecular Neuroscience and 5 papers in Physiology. Recurrent topics in Begoña Brera's work include Neurological disorders and treatments (7 papers), Parkinson's Disease Mechanisms and Treatments (6 papers) and Alzheimer's disease research and treatments (5 papers). Begoña Brera is often cited by papers focused on Neurological disorders and treatments (7 papers), Parkinson's Disease Mechanisms and Treatments (6 papers) and Alzheimer's disease research and treatments (5 papers). Begoña Brera collaborates with scholars based in Spain, Colombia and Czechia. Begoña Brera's co-authors include Marı́a L. de Ceballos, Ana M. Martín‐Moreno, Eva Carro, Mercedes Delgado, Carlos Spuch, Miguel A. Pozo, Antonio Cuadrado, Luis Garcı́a-Garcı́a, Nadia G. Innamorato and María‐Ángeles Arévalo and has published in prestigious journals such as Blood, Journal of neurosurgery and Neurobiology of Disease.

In The Last Decade

Begoña Brera

16 papers receiving 572 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Begoña Brera Spain 9 246 197 175 145 79 16 579
Hiroko Tsunekawa Japan 11 153 0.6× 110 0.6× 143 0.8× 135 0.9× 60 0.8× 13 496
Marta Zamarbide Spain 14 184 0.7× 169 0.9× 104 0.6× 264 1.8× 68 0.9× 21 679
Roberta Facchinetti Italy 13 117 0.5× 127 0.6× 158 0.9× 103 0.7× 125 1.6× 15 481
Ernest Palomer Spain 17 265 1.1× 125 0.6× 346 2.0× 453 3.1× 137 1.7× 22 920
Ivica Granic Netherlands 9 126 0.5× 89 0.5× 194 1.1× 174 1.2× 130 1.6× 12 496
T Kihara Japan 9 368 1.5× 294 1.5× 206 1.2× 561 3.9× 83 1.1× 12 972
Gilles Bru‐Mercier United Kingdom 10 252 1.0× 62 0.3× 194 1.1× 264 1.8× 59 0.7× 18 641
Wang Jun China 7 154 0.6× 103 0.5× 241 1.4× 100 0.7× 152 1.9× 10 484
Francesca Cerbai Italy 8 162 0.7× 121 0.6× 113 0.6× 111 0.8× 183 2.3× 8 448
Asha Naidu United States 7 281 1.1× 172 0.9× 668 3.8× 286 2.0× 181 2.3× 8 794

Countries citing papers authored by Begoña Brera

Since Specialization
Citations

This map shows the geographic impact of Begoña Brera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Begoña Brera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Begoña Brera more than expected).

Fields of papers citing papers by Begoña Brera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Begoña Brera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Begoña Brera. The network helps show where Begoña Brera may publish in the future.

Co-authorship network of co-authors of Begoña Brera

This figure shows the co-authorship network connecting the top 25 collaborators of Begoña Brera. A scholar is included among the top collaborators of Begoña Brera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Begoña Brera. Begoña Brera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Navarro‐Dorado, Jorge, Nuria Villalba, Dolores Prieto, et al.. (2016). Vascular Dysfunction in a Transgenic Model of Alzheimer's Disease: Effects of CB1R and CB2R Cannabinoid Agonists. Frontiers in Neuroscience. 10. 422–422. 16 indexed citations
2.
Pérez‐González, Rocío, Desireé Antequera, Miguel Garzón, et al.. (2014). Leptin gene therapy attenuates neuronal damages evoked by amyloid-β and rescues memory deficits in APP/PS1 mice. Gene Therapy. 21(3). 298–308. 61 indexed citations
3.
Martín‐Moreno, Ana M., Begoña Brera, Carlos Spuch, et al.. (2012). Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice. Journal of Neuroinflammation. 9(1). 8–8. 201 indexed citations
4.
Fernández-Tomé, Paz, Begoña Brera, María‐Ángeles Arévalo, & Marı́a L. de Ceballos. (2004). β-Amyloid25-35 inhibits glutamate uptake in cultured neurons and astrocytes: modulation of uptake as a survival mechanism. Neurobiology of Disease. 15(3). 580–589. 64 indexed citations
5.
Ceballos, Marı́a L. de, et al.. (2001). β-Amyloid-Induced Cytotoxicity, Peroxide Generation and Blockade of Glutamate Uptake in Cultured Astrocytes. Clinical Chemistry and Laboratory Medicine (CCLM). 39(4). 317–8. 5 indexed citations
6.
Brera, Begoña, et al.. (2000). β-Amyloid Peptides Are Cytotoxic to Astrocytes in Culture: A Role for Oxidative Stress. Neurobiology of Disease. 7(4). 395–405. 52 indexed citations
7.
Bravo, Gonzalo, et al.. (1999). Clinical outcome of cotransplantation of peripheral nerve and adrenal medulla in patients with Parkinson's disease. Journal of neurosurgery. 90(5). 875–882. 11 indexed citations
8.
Bravo, Guadalupe, et al.. (1997). Regression of Parkinsonian fetal ventral mesencephalon grafts upon withdrawal of cyclosporine a immunosuppression. Transplantation Proceedings. 29(1-2). 977–980. 8 indexed citations
10.
Bravo, Gonzalo, et al.. (1996). Clinical experience with cotransplantation of peripheral nerve and adrenal medulla in patients with Parkinson’s disease. Transplant International. 9 Suppl 1. 485–491. 5 indexed citations
11.
Bravo, Gonzalo, et al.. (1996). Clinical experience with cotransplantation of peripheral nerve and adrenal medulla in patients with Parkinson's disease. Transplant International. 9(s1). S485–S491. 4 indexed citations
12.
Bravo, Guadalupe, et al.. (1995). Long-term follow-up in 10 Parkinson's disease patients subjected to fetal brain grafting into a cavity in the caudate nucleus: the Clinica Puerta de Hierro experience. CPH Neural Transplantation Group.. PubMed. 27(1). 1395–400. 13 indexed citations
13.
Fernández‐Millán, Elisa, Astrid M. Vicente, A. Zapata, et al.. (1994). Establishment and characterization of cloned human thymic epithelial cell lines. Analysis of adhesion molecule expression and cytokine production. Blood. 83(11). 3245–3254. 2 indexed citations
15.
Brera, Begoña, et al.. (1993). Neural transplants in Parkinson's disease. CPH Neural Transplantation Group.. PubMed. 25(1 Pt 2). 1005–11. 5 indexed citations
16.
Brera, Begoña, et al.. (1989). Preparation of adrenal medullary tissue for transplantation in Parkinson's disease: a new procedure. Journal of neurosurgery. 71(3). 452–454. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026